OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
20 hedge funds and large institutions have $1.31M invested in OncoSec Medical Incorporated in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
9% less funds holding
Funds holding: 22 → 20 (-2)
13% less capital invested
Capital invested by funds: $1.51M → $1.31M (-$196K)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$220K |
| 2 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$89.9K |
| 3 |
SM
Salzhauer Michael
|
+$37.2K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$20.6K |
| 5 |
LPL Financial
San Diego,
California
|
+$15.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$222K |
| 2 |
JP Morgan Chase
New York
|
-$220K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8.86K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$3K |
| 5 |
Morgan Stanley
New York
|
-$2.8K |
ONCS Hedge Fund Activity: Q4 2019 in Review
20 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2019, worth a combined $1.31M — down 13% from $1.51M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ONCS and 1 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $220K. The largest seller was 683 Capital Management, cutting an estimated $222K.
- 20 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2019, down from 22 in Q3 2019.
- Funds reported $1.31M of OncoSec Medical Incorporated stock for Q4 2019, down 13% quarter-over-quarter.
- 1 fund opened new OncoSec Medical Incorporated positions in Q4 2019 and 3 closed out, a net change of -2 holders.
- The largest OncoSec Medical Incorporated buyer in Q4 2019 was Renaissance Technologies, an estimated $220K added.
- The largest OncoSec Medical Incorporated seller in Q4 2019 was 683 Capital Management, an estimated $222K sold.
Based on aggregated 13F filings for Q4 2019.